Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
immune response
|
| gptkbp:category |
oil-in-water emulsion adjuvant
|
| gptkbp:contains |
gptkb:polysorbate_80
gptkb:DL-α-tocopherol gptkb:squalene |
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:function |
enhances immune response
|
| https://www.w3.org/2000/01/rdf-schema#label |
AS03
|
| gptkbp:purpose |
dose sparing
increase vaccine efficacy |
| gptkbp:regulates |
gptkb:European_Medicines_Agency
gptkb:Health_Canada |
| gptkbp:sideEffect |
fever
fatigue headache muscle pain injection site pain rare cases of narcolepsy (association debated) |
| gptkbp:usedDuring |
gptkb:2009_H1N1_pandemic
|
| gptkbp:usedIn |
gptkb:H1N1_vaccine
COVID-19 vaccine candidates pandemic influenza vaccines |
| gptkbp:bfsParent |
gptkb:Pandemrix
gptkb:GBP510_COVID-19_vaccine |
| gptkbp:bfsLayer |
7
|